The Phenomenon of Multidrug Resistance in GlioblastomasAlexander N. Chernov, О. В. Шамова, Diana Alaverdian et al.|Hematology/Oncology and Stem Cell Therapy|2021Cited by 27
Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration of Human U251 Glioma CellsAlexander N. Chernov, О. В. Шамова, Т. А. Филатенкова et al.|Molecules|2022Cited by 16
In Vitro Evaluation of the Cytotoxic Effect of Streptococcus pyogenes Strains, Protegrin PG-1, Cathelicidin LL-37, Nerve Growth Factor and Chemotherapy on the C6 Glioma Cell LineAlexander N. Chernov, А. Н. Суворов, Mariia A. Suvorova et al.|Molecules|2022Cited by 15
Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cellsAlexander N. Chernov, О. В. Шамова, Alexander Kim et al.|Cancer Chemotherapy and Pharmacology|2024Cited by 10
Nerve Growth Factor, Antimicrobial Peptides and Chemotherapy: Glioblastoma Combination Therapy to Improve Their EfficacyAlexander N. Chernov, О. В. Шамова, I. V. Kudryavtsev et al.|Biomedicines|2023Cited by 7